首页 | 本学科首页   官方微博 | 高级检索  
检索        


Neurocognitive outcome in patients with hypertyrosinemia type I after long-term treatment with NTBC
Authors:Eva Thimm  Renate Richter-Werkle  Gudrun Kamp  Bettina Molke  Diran Herebian  Dirk Klee  Ertan Mayatepek  Ute Spiekerkoetter
Institution:(1) Department of General Pediatrics, Medical Faculty, University Dusseldorf, Moorenstrasse 5, 40225 D?sseldorf, Germany;(2) Medical Faculty, Institute for Diagnostic Radiology, University Dusseldorf, 40225 Dusseldorf, Germany
Abstract:

Objective  

The implementation of NTBC into treatment of hypertyrosinemia type I (HT I) greatly improved survival by prevention of acute liver failure and hepatocellular carcinoma. However, there are first reports of cognitive impairment in patients with elevated plasma tyrosine concentrations.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号